| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| AquaVenture Holdings (WAAS) | Citigroup/ Deutsche Bank Securities/ RBC Capital Markets | $100.00 | n.a. | |||
| Bioceres S.A. (BIOX) | Piper Jaffray/ Itaú BBA | $80.50 | n.a. | |||
| ETRE Residential, LLC (EPNT) | TBA | $35.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| NeuroSigma (NSIG) | Jefferies | 3.57 | $13.00 | $15.00 | $50.00 | n.a. |
| Par Pharmaceutical Holdings (PRX) | J.P. Morgan/ Goldman Sachs | $100.00 | n.a. | |||
| New Terms | ||||||
| Aclaris Therapeutics (ACRS) | Jefferies/ Citigroup | 5.00 | $14.00 | $16.00 | $75.00 | n.a. |
| Albertsons Companies (ABS) | Goldman Sachs/ BofA Merrill Lynch/ Citigroup/ Morgan Stanley/Deutsche Bank Securities/ Credit Suisse/ Barclays | $100.00 | n.a. | |||
| CPI Card Group (PMTS) | BMO Capital Markets/ Goldman Sachs/ CIBC | 17.65 | $16.00 | $18.00 | $300.00 | n.a. |
| Digicel Group (DCEL) | J.P. Morgan/ UBS Investment Bank/ Citigroup/ Barclays/ Credit Suisse/ Deutsche Bank Securities | 124.14 | $13.00 | $16.00 | $1,800.00 | n.a. |
| Edge Therapeutics (EDGE) | Leerink Partners/ Credit Suisse | 5.67 | $14.00 | $16.00 | $85.00 | 2-Stars |
| New Business Netherlands N.V (Ferrari N.V.) (FRRI) | UBS Investment Bank/ BofA Merrill Lynch/ Santander | $100.00 | n.a. | |||
| NovoCure (NVCR) | J.P. Morgan/ Deutsche Bank Securities/ Evercore ISI/ Wells Fargo Securities | 12.50 | $26.00 | $29.00 | $343.75 | 2-Stars |
| Performance Food Group (PFGC) | Credit Suisse/ Barclays/ Wells Fargo Securities/ Morgan Stanley | 14.50 | $22.00 | $25.00 | $340.75 | 2-Stars |
| Pure Storage (PSTG) | Morgan Stanley/ Goldman Sachs/ Barclays/ Allen & Company/ BofA Merrill Lynch | 25.00 | $16.00 | $18.00 | $425.00 | n.a. |
| Strongbridge Biopharma plc (SBBP) | BofA Merrill Lynch/ Stifel | 4.25 | $17.93 | $17.93 | $76.20 | N/C |
| Surgery Partners (SGRY) | BofA Merrill Lynch/ Goldman Sachs/ Jefferies | 14.29 | $23.00 | $26.00 | $349.98 | 2-Stars |
| N/C = No Call – Stock has been traded on the Norwegian Over-The-Counter System since 2002 | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 21, 2015 | Manager(s) | Offered | Raised | Price | 9/21/15 | Change |
| Boulevard Acquisition Corp. II (BLVDU) (u) | Citigroup | 35.00 | $350.00 | $10.00 | $9.98 | -0.20% |
| u (unit offering) | ||||||
